Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record.

Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus

Pryor, Betty D., Bologna, Saba G., Kahl, Leslie E.·1996·Arthritis & Rheumatism

Abstract

Objective. To determine risk factors for serious infection during treatment with cyclophosphamide (CYC) and high‐dose corticosteroids in systemic lupus erythematosus (SLE). Methods. Records of 100 SLE patients who had received CYC were examined for documentation of serious infections that occurred during CYC therapy and the subsequent 3 months. Results. Infection occurred in 45 of 100 patients during CYC therapy. Patients with infection were more likely to have multiple organ disease (49% versus 29%; P = 0.04), a lower nadir in the white blood cell (WBC) count (2,818 versus 3,558 cells/μl; P = 0.02), and a higher maximum corticosteroid dose (195 versus 73 mg; P ≤ 0.01) than patients without infection. Infection occurred with equal prevalence in those who received intravenous (IV) (39%) or oral (40%) CYC, but was more common with use of sequential IV and oral therapy (68%). By multivariate analysis, the strongest association with infection was a WBC nadir ≤3,000 cells/μl (odds ratio [OR] 2.8, 95% confidence interval [95% CI] 1.4–5.5) and use of sequential IV and oral CYC (OR 2.3, 95% CI 1.2–4.3). Infection occurred in more CYC‐treated patients taking concomitant steroids than in those treated with high‐dose steroids alone (45% versus 12%; P = 0.001). Fatal and opportunistic infections during CYC therapy were associated with a low WBC nadir and a high maximum corticosteroid dose. Conclusion. The risk of serious infection in patients with SLE is influenced by the inclusion of CYC in the treatment regimen. The likelihood of infection in this setting is enhanced by CYC‐induced reductions in the total WBC count <3,000 cells/μl and by sequential IV and oral therapy. Both of these factors may be indicators of aggressive cytotoxic treatment, underscoring the need for close observation during treatment to minimize the risk of serious infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.1780390906

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 236

Metadata

Authors
Pryor, B. D., Bologna, S. G., & Kahl, L. E.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
1996-09
Volume
39
Issue
9
Pages
1475-1482
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2100317664
Cited by
236
References
0
FWCI
3.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.1780390906
The paper
Pryor, B. D., Bologna, S. G., & Kahl, L. E. (1996). Risk factors for serious infection during treatment with cyclophosphamide and high‐dose corticosteroids for systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390906

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.